Photopharmacology of Quinoline and Benzimidazole Azobenzene-Based Photoswitchable β‑Hematin Inhibitors.

ABSTRACT: Recent advances in antimicrobial drug design have incorporated photopharmacology to control drug behavior through light activation, alongside traditional phenotypical strategies including molecular hybridization and metal incorporation. The quinoline and benzimidazole scaffolds are important chemical frameworks identified by the Medicines for Malaria Venture and are known to exert their antiplasmodial activity by inhibiting hemozoin formation, an important target in antimalarial drug design. These scaffolds form part of growing libraries in drug discovery, aimed at developing novel and potent antimalarial agents through structural modifications that improve pharmacological profiles and overcome drug resistance. Consequently, in this study, azobenzene photoswitchable chemical entities have

SUBMITTER: Golding TM 

PROVIDER: S-EPMC12824741 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature